Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Benelux Stocks: ASML, Option, Recticel and Spector Shares Move

Don't Miss Out —
Follow us on:

Aug. 31 (Bloomberg) -- The Amsterdam Exchanges Index rose 0.92, or 0.3 percent, to 316.47, reversing yesterday’s decline. Belgium’s Bel20 Index fell 0.1 percent to 2,457.46 today.

The following are among the most active stocks in the Benelux markets today. Symbols are in parentheses.

Dutch stocks:

Amsterdam Commodities NV (ACOMO NA) rose 3.8 percent to 8.25 euros, after two days of declines. The world’s largest trader of spices proposed to pay an interim dividend of 11 eurocents a share, from 10 cents a year earlier.

Amsterdam Molecular Therapeutics Holding NV (AMT NA) dropped 12 percent to 2.13 euros, the biggest drop since October 2008. The developer of treatments for rare genetic disorders said its first-half loss widened to 9.8 million euros from 9.4 million euros.

AND International Publishers NV (AND NA) soared 9.3 percent to 4.48 euros, gaining for a fourth day. The Dutch mapmaker expects full-year profit to rise to at least 2.3 million euros ($2.9 million) from 1.5 million euros a year earlier.

ASML Holding NV (ASML NA) tumbled 3 percent to 19.68 euros, to close at the lowest level since November. Europe’s biggest maker of semiconductor equipment was cut to “hold” from “buy” at Deutsche Bank AG.

Ctac NV (CTAC NA) plunged 11 percent to 2.12 euros, reversing yesterday’s 7 percent rise. The Dutch distributor of SAP AG business-management software said it doesn’t expect “market conditions in the ICT sector to improve significantly in the second half of this year.” The company said it expects a “modest” full-year profit.

Macintosh Retail Group NV (MACIN NA) rose 1.2 percent to 15.35 euros, partly offsetting yesterday’s 5.3 percent drop. The owner of Dolcis and Manfield shoe stores said the second half of the year started well, adding it’s “too early yet to speak of a trend breakthrough.”

Belgian stocks:

Ion Beam Applications SA (IBAB BB) slipped 1 percent to 7.75 euros, following two days of advances. Europe’s largest maker of proton-therapy equipment said first-half net income fell 24 percent to 2.31 million euros. The company, which is studying strategic options for its pharmaceuticals unit, said it’s still in talks about an offer it received for a 60 percent stake in its in-vitro diagnostics business and that the offer doesn’t meet all of its requirements.

Option NV (OPTI BB), the Belgian maker of wireless data-access devices that raised 20.2 million euros in a rights offer in December, fell 23 percent to 44 cents, the biggest fall since March 2009. The company had 7.65 million euros of cash left at the end of June, following a 20.5 million-euro loss in the first half.

Separately, KBC Groep NV cut its recommendation on the stock to “sell” from “hold.”

Recticel SA (REC BB) fell 4.6 percent to 7.10 euros, paring four days of gains. The Belgian maker of foam, car-interior trim and Lattoflex mattresses said first-half profit was 13.2 million euros and reconfirmed its full-year guidance for operating profit and debt reduction.

‘Higher raw material costs have offset part of the operating leverage and of positive effects of the restructuring efforts made last year,” Brussels-based analyst Bernard Hanssens at Bank Degroof wrote in a note today.

Spector Photo Group NV (SPEC BB) dropped 8.8 percent to 62 cents, the biggest drop since Dec. 11, 2008. The photography company that owns the Photo Hall stores said its first-half net loss widened to 6.32 million euros.

To contact the reporter on this story: Maud van Gaal in Amsterdam at mvangaal@bloomberg.net.

To contact the editor responsible for this story: Frank Connelly at fconnelly@bloomberg.net.